Merck & Co., Inc. (BCBA:MRK)

Elevation Oncology Revenue

Merck & Co. had revenue of $15.81B USD in the quarter ending June 30, 2025, a decrease of -1.90%. This brings the company's revenue in the last twelve months to $63.62B, up 1.82% year-over-year. In the year 2024, Merck & Co. had annual revenue of $64.17B with 6.74% growth.

• Revenue (ttm): $63.62B
• Revenue Growth: +1.82%
• P/S Ratio: 3.48
• Revenue / Employee: $848.21K
• Employees: 75,000
• Market Cap: 263.84T

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	64.17B	4.05B	6.74%
Dec 31, 2023	60.12B	832.00M	1.40%
Dec 31, 2022	59.28B	10.58B	21.72%
Dec 31, 2021	48.70B	7.19B	17.31%
Dec 31, 2020	41.52B	2.40B	6.13%